{"id":265941,"date":"2020-08-20T06:01:14","date_gmt":"2020-08-20T10:01:14","guid":{"rendered":"https:\/\/canadianinquirer.net\/v1\/?p=265941"},"modified":"2020-08-20T06:01:14","modified_gmt":"2020-08-20T10:01:14","slug":"fda-to-act-on-erroneously-labeled-product","status":"publish","type":"post","link":"https:\/\/canadianinquirer.net\/v1\/2020\/08\/20\/fda-to-act-on-erroneously-labeled-product\/","title":{"rendered":"FDA to act on erroneously labeled product"},"content":{"rendered":"
\"\"<\/a>
Roque said the FDA should decide on the matter since it is the agency responsible for regulating drugs, medical devices, food, cosmetics, and toys. (PCOO file photo)<\/figcaption><\/figure>\n

MANILA<\/strong>\u00a0\u2013 Malaca\u00f1ang is leaving it to the Food and Drug Administration (FDA) to decide on banning the distribution of a locally-made beauty product line bearing an address \u201cManila Province, P.R. China.\u201d<\/p>\n

Presidential Spokesperson Harry Roque made this remark after Puwersa ng Bayaning Atleta (PBA) Partylist Rep. Jericho Nograles wrote the Department of Trade and Industry (DTI) and FDA to complain the manufacturer of the Chinese hair care product, Ashley Shine Keratin Treatment Deep Repair has \u201c1st Flr. 707 Ito Cristo St., San Nicolas, Manila Province, P.R. China\u201d as its address on its packaging.<\/p>\n

Roque said the FDA should decide on the matter since it is the agency responsible for regulating drugs, medical devices, food, cosmetics, and toys.<\/p>\n

\u201cTingin ko po ang<\/em>\u00a0FDA\u00a0ay nagdedesisyon diyan dahil<\/em>\u00a0there are criteria for blacklisting. I think one of those\u00a0is kung merong banta sa kalusugan ng gagamit nito<\/em>(I think the FDA will make a decision on that because there are criteria for blacklisting. I think one of those is if there is a threat to health). So let\u2019s allow the FDA to exercise their exclusive jurisdiction\u00a0pagdating sa bagay na \u2018yan<\/em>\u00a0(when it comes to that issue),\u201d he said in a virtual Palace briefing.<\/p>\n

He shrugged off concerns it was insulting, saying anyone would believe in the address written on the packaging.<\/p>\n

\u201cAng sakin kalokohan lang po \u2018yan. Hindi dapat pinapansin \u2018yan dahil wala namang naniniwala na tayo\u2019y probinsya ng Tsina<\/em>\u00a0(For me, that\u2019s just nonsense. It should not be given attention because nobody believes that we\u2019re the province of China),\u201d he said.<\/p>\n

According to Roque, Filipinos would never allow the country to be dominated by any foreign country.<\/p>\n

\u201cLahat ng Pilipino ay nagmamahal sa bayan<\/em>\u00a0(All Filipinos love their country). We are proud to be Filipinos and we will never allow to be subjugated by any foreign power,\u201d he said.<\/p>\n

In his letter to the DTI and FDA, Nograles asked the agencies to investigate the matter, saying that \u201cany act to undermine our sovereignty must be taken seriously\u201d.<\/p>\n

\u201cIt is in this light that we respectfully ask your Office to immediately investigate this detestable and repulsive offense against our nation, and, if legally justified, prohibit the continued distribution of these products in our country,\u201d Nograles said in the letter.<\/p>\n

Based on the information received by his office, Nograles said the Chinese product bearing the address was manufactured in 2018 and is still distributed throughout the country.<\/p>\n

He said the product is being distributed by Elegant Fumes Beauty Products Inc., a Binondo-based company owned by a Chinese national.<\/p>\n

Last May, a geotag that identified the Philippines as \u201cProvince of China\u201d and \u201cNorth Philippines, Province of China\u201d on social media apps Facebook and Instagram made headlines.<\/p>\n

Malaca\u00f1ang called on fact verifiers to flag the geotag, stressing that it was their job as fact-checkers to prevent fake news from spreading on social media.<\/p>\n","protected":false},"excerpt":{"rendered":"

MANILA\u00a0\u2013 Malaca\u00f1ang is leaving it to the Food and Drug Administration (FDA) to decide on banning the distribution of a …<\/p>\n","protected":false},"author":44,"featured_media":259982,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16,95],"tags":[],"class_list":["post-265941","post","type-post","status-publish","format-standard","has-post-thumbnail","category-news","category-news-ph","mauthors-azer-parrocha","mauthors-philippine-news-agency"],"_links":{"self":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts\/265941","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/users\/44"}],"replies":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/comments?post=265941"}],"version-history":[{"count":1,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts\/265941\/revisions"}],"predecessor-version":[{"id":265947,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts\/265941\/revisions\/265947"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/media\/259982"}],"wp:attachment":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/media?parent=265941"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/categories?post=265941"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/tags?post=265941"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}